Must Read: Bristol-Myers Squibb: Our Top Healthcare Pick For The Rest Of 2021

Seeking Alpha's Must Reads Bristol-Myers Squibb: Our Top Healthcare Pick For The Rest Of 2021 While we cherish all amongst our Healthcare mix, we believe that Bristol-Myers Squibb (BMY) rightfully earns our "Top Pick" title for the rest of the year. The stock offers a considerably charming. Why Coinbase Is A Safer Crypto And Blockchain Play Than Buying Bitcoin Before the haters begin raiding the comments section, no I'm not a Bitcoin hater. I'm fully in support of Bitcoin (BTC-USD) and Ethereum (ETH-USD), and crypto as a viable currency, which is actuall... Time For A Second Look At Snowflake Snowflake Inc. (SNOW), the cloud data platform company, has seen a sharp decline since the sector rotation out of high-growth tech stocks. Shares are down around 50% from the 52-week-high. Might th... S&P 500: Why Stocks Are Headed Higher From Here The S&P 500/SPX (SP500) has appreciated by close to 50% over the last year. However, despite these stellar gains, the market likely has a great deal of upside going forward. We are in a bull market. IBM: Things Are Changing I have written positively about International Business Machines (NYSE:IBM) for some time on Seeking Alpha. In fact, I even included IBM in my Top 3 Dividend Growth Stocks for 2021. There are some r... Download Seeking Alpha for your Phone or Tablet Do you like the content of the Must Reads? How can we improve? Just reply to this email. Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017 By default, clicking links in Seeking Alpha emails auto-logs you into the site. Be careful not to forward this email to anyone you don't want having access to your account. You can change your email security settings here (keep in mind that disabling email auto-login will likely require you to log into your account more frequently). Why are you receiving this? You subscribed to Must Reads at Seeking Alpha. Don't like this email? Unsubscribe here.

Share this

Share on FacebookPlus on Google+